4//SEC Filing
CORRIGAN MARK 4
Accession 0001104659-18-051500
CIK 0000827809other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 4:30 PM ET
Size
5.7 KB
Accession
0001104659-18-051500
Insider Transaction Report
Form 4
CORRIGAN MARK
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-08-09+50,000→ 50,000 totalExercise: $3.33Exp: 2028-08-09→ Common Shares (50,000 underlying)
Footnotes (2)
- [F1]Each option has an exercise price equal to the closing price of a common share of the Issuer on the Nasdaq Global Select Market on the grant date.
- [F2]The option shall vest in twelve equal monthly installments, beginning one month after the grant date.
Documents
Issuer
NOVELION THERAPEUTICS INC.
CIK 0000827809
Entity typeother
Related Parties
1- filerCIK 0001250661
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 4:30 PM ET
- Size
- 5.7 KB